Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FP1PH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,714
Award facts
- Contract value 100% obligated
- $16,714.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Cosentyx (secukinumab) 300 mg in 2 mL pen format. This order has a ceiling value of $16,714.23 and is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026. The contract was competitively awarded without a set-aside designation. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract vehicle with the DLA Troop Support Medical, which carries a potential value of $999,999,999.00 and extends through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds this comprehensive pharmaceutical support contract that enables the supply of a broad range of medical products, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, particularly for Department of Defense medical procurement needs. The company's federal contract portfolio demonstrates extensive experience delivering specialized medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Cosentyx order under this award reflects the ongoing demand for specialty pharmaceutical products within the military medical supply chain, supporting treatment requirements across military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FP1PH?
SPE2DR26FP1PH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FP1PH worth?
The government has obligated $16,714 on SPE2DR26FP1PH.
Is contract SPE2DR26FP1PH an order under another contract?
Yes. SPE2DR26FP1PH is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1PH competed?
The extent of competition for SPE2DR26FP1PH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award